Multimodal Imaging and Detection Strategy With 124 I-Labeled Chimeric Monoclonal Antibody cG250 for Accurate Localization and Confirmation of Extent of Disease During Laparoscopic and Open Surgical Resection of Clear Cell Renal Cell Carcinoma

Documenti analoghi

• PET/CT imaging of clear cell renal cell carcinoma with (124)I labeled chimeric antibody
  di: Bahnson, Eamonn E., et al.
  Pubblicazione: (2009)
• Multimodal imaging and detection approach to ¹⁸F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience
  di: Povoski Stephen P, et al.
  Pubblicazione: (2011-11-01)
• Multimodal imaging and detection approach to (18)F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience
  di: Povoski, Stephen P, et al.
  Pubblicazione: (2011)
• ImmunoPET Imaging of Renal Cell Carcinoma with (124)I- and (89)Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice
  di: Stillebroer, Alexander B., et al.
  Pubblicazione: (2013)
• Pairwise Comparison of (89)Zr- and (124)I-labeled cG250 Based on Positron Emission Tomography Imaging and Non-Linear Immunokinetic Modeling: In Vivo Carbonic Anhydrase IX Receptor Binding and Internalization in Mouse Xenografts of Clear Cell Renal Carcinoma
  di: Cheal, Sarah M., et al.
  Pubblicazione: (2014)